NeuroSky
PrivateLast Round
Series D
Nov 7, 2013
Total Funding Raised
$20.17M
Company Overview
NeuroSky is a biosensor technology company that develops and manufactures brain-computer interface (BCI), EEG, and ECG technologies for consumer and commercial applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sensors, Health IoT, Consumer Electronics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroSky Comparables
Compare NeuroSky with similar companies based on industry and business-model similarity.
NeuroSky Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 7, 2013 | ||||
| Series C | Jun 22, 2010 |
NeuroSky Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwan United Venture Capital Corporation | Series A |
| SoftBank Group | Series D |
| WR Hambrecht + Co | Series A, Series C |
| YFY Biotech Management Company | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2025
Monthly visitors increased 4690% MoM, reaching 47.9K.
- Nov 7, 2013
Raised Series C round
NeuroSky Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NeuroSky's valuation, stock price, and market status.
Is NeuroSky a public or private company?
NeuroSky is a private company.
What is the current stock price of NeuroSky?
NeuroSky is a private company with no public stock price. No recent secondary market data is available.
How much is NeuroSky worth (valuation)?
Valuation information for NeuroSky is not publicly available.
Can I buy NeuroSky stock?
NeuroSky shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NeuroSky's last funding round?
NeuroSky's most recent funding round was Series C on November 7, 2013.
Who are the main investors in NeuroSky?
Key investors in NeuroSky include SoftBank Group, WR Hambrecht.
Will NeuroSky IPO soon?
No public IPO plans have been announced for NeuroSky.
How can I track NeuroSky secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroSky's secondary market activity and sign up for updates.